Cerity Partners LLC Makes New $60,000 Investment in Aurora Cannabis Inc. (NYSE:ACB)

Cerity Partners LLC acquired a new stake in Aurora Cannabis Inc. (NYSE:ACBGet Rating) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 45,358 shares of the company’s stock, valued at approximately $60,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Exchange Traded Concepts LLC acquired a new stake in shares of Aurora Cannabis in the 2nd quarter valued at $34,000. MQS Management LLC acquired a new stake in shares of Aurora Cannabis in the 1st quarter valued at $49,000. HighTower Advisors LLC acquired a new stake in shares of Aurora Cannabis in the 1st quarter valued at $50,000. CWM LLC raised its holdings in shares of Aurora Cannabis by 1,370.0% in the 2nd quarter. CWM LLC now owns 41,776 shares of the company’s stock valued at $55,000 after purchasing an additional 38,934 shares in the last quarter. Finally, Citigroup Inc. raised its holdings in shares of Aurora Cannabis by 566.4% in the 1st quarter. Citigroup Inc. now owns 14,334 shares of the company’s stock valued at $57,000 after purchasing an additional 12,183 shares in the last quarter. 29.53% of the stock is currently owned by institutional investors and hedge funds.

Aurora Cannabis Trading Up 1.5 %

Shares of Aurora Cannabis stock opened at $1.33 on Thursday. Aurora Cannabis Inc. has a 1 year low of $0.98 and a 1 year high of $6.94. The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.19 and a current ratio of 4.07. The company has a market capitalization of $399.52 million, a P/E ratio of -0.21 and a beta of 2.60. The company’s fifty day moving average is $1.27 and its two-hundred day moving average is $1.53.

Aurora Cannabis (NYSE:ACBGet Rating) last issued its quarterly earnings data on Tuesday, September 20th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.04. Aurora Cannabis had a negative net margin of 838.11% and a negative return on equity of 46.40%. The company had revenue of $39.35 million for the quarter, compared to the consensus estimate of $39.23 million. Analysts forecast that Aurora Cannabis Inc. will post -0.34 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ACB. Atb Cap Markets upgraded shares of Aurora Cannabis from an “underperform” rating to a “sector perform” rating in a report on Thursday, September 22nd. Canaccord Genuity Group raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Wednesday, September 21st. Canaccord Genuity Group raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Wednesday, September 21st. Finally, Piper Sandler dropped their target price on shares of Aurora Cannabis from $4.00 to $3.00 and set a “neutral” rating on the stock in a research report on Wednesday, September 21st. Five analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Aurora Cannabis has an average rating of “Hold” and an average target price of $3.20.

About Aurora Cannabis

(Get Rating)

Aurora Cannabis, Inc engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Further Reading

Want to see what other hedge funds are holding ACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aurora Cannabis Inc. (NYSE:ACBGet Rating).

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.